The role of multidisciplinary care in managing sarcoma in low- and middle-income countries: a focus on treatment outcomes

Sarcomas are a heterogeneous group of rare malignancies requiring complex and individualized management strategies. In high-income settings, multidisciplinary care (MDC) has been shown to improve diagnostic accuracy, optimize treatment planning, and enhance patient outcomes. However, the role and implementation of MDC in managing sarcoma within low- and middle-income countries (LMICs) remain underexplored. This paper critically examines the impact of multidisciplinary care models on treatment outcomes for sarcoma patients in LMICs, highlighting current practices, barriers, and opportunities for improvement. Drawing on data from peer-reviewed literature, institutional reports, and global cancer care guidelines, we analyze how team-based approaches involving surgical oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, and supportive care specialists influence early diagnosis, resection margins, recurrence rates, and survival outcomes. Findings indicate that while MDC improves adherence to evidence-based guidelines and fosters coordinated care, its effectiveness in LMICs is limited by workforce shortages, infrastructural deficits, and fragmented health systems. Nevertheless, innovative approaches such as virtual tumor boards, regional centers of excellence, and task-shifting models show promise in bridging gaps. Case studies from selected LMICs demonstrate that even in resource-constrained settings, structured multidisciplinary interventions can lead to earlier diagnosis, improved surgical planning, reduced treatment delays, and better quality of life (QoL). We conclude that scaling up MDC for sarcoma care in LMICs requires sustained investment in health system strengthening, interprofessional training, and policy support. Emphasizing locally adaptable MDC frameworks could significantly enhance sarcoma outcomes and contribute to closing the global cancer care gap.

Authors

Institutions

Publication Details

Journal
International Journal of Research in Orthopaedics
Published
2025-08-25
DOI
https://doi.org/10.18203/issn.2455-4510.intjresorthop20252667
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of multidisciplinary care in managing sarcoma in low- and middle-income countries: a focus on treatment outcomes

Oluwafemi Ajibola, Adewunmi Akingbola, Abiodun Adegbesan, Jemiludeen O. Morhason-Bello et al.
International Journal of Research in Orthopaedics
Sarcoma Diagnosis and Treatment
article

The role of multidisciplinary care in managing sarcoma in low- and middle-income countries: a focus on treatment outcomes

Oluwafemi Ajibola, Adewunmi Akingbola, Abiodun Adegbesan, Jemiludeen O. Morhason-Bello, Joel Chuku, Adebayo Adebayo Mobolaji, Adebolu Badejo
article en

Abstract

Sarcomas are a heterogeneous group of rare malignancies requiring complex and individualized management strategies. In high-income settings, multidisciplinary care (MDC) has been shown to improve diagnostic accuracy, optimize treatment planning, and enhance patient outcomes. However, the role and implementation of MDC in managing sarcoma within low- and middle-income countries (LMICs) remain underexplored. This paper critically examines the impact of multidisciplinary care models on treatment outcomes for sarcoma patients in LMICs, highlighting current practices, barriers, and opportunities for improvement. Drawing on data from peer-reviewed literature, institutional reports, and global cancer care guidelines, we analyze how team-based approaches involving surgical oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, and supportive care specialists influence early diagnosis, resection margins, recurrence rates, and survival outcomes. Findings indicate that while MDC improves adherence to evidence-based guidelines and fosters coordinated care, its effectiveness in LMICs is limited by workforce shortages, infrastructural deficits, and fragmented health systems. Nevertheless, innovative approaches such as virtual tumor boards, regional centers of excellence, and task-shifting models show promise in bridging gaps. Case studies from selected LMICs demonstrate that even in resource-constrained settings, structured multidisciplinary interventions can lead to earlier diagnosis, improved surgical planning, reduced treatment delays, and better quality of life (QoL). We conclude that scaling up MDC for sarcoma care in LMICs requires sustained investment in health system strengthening, interprofessional training, and policy support. Emphasizing locally adaptable MDC frameworks could significantly enhance sarcoma outcomes and contribute to closing the global cancer care gap.

International Journal of Research in OrthopaedicsVol. 11(5)
Rutgers, The State University of New Jersey (US), African Institute for Mathematical Sciences (ZA), University of Ibadan (NG), University of Cambridge (GB), University College Hospital, Ibadan (NG), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), V. N. Karazin Kharkiv National University (UA)
Openalex Percentile: Top 67%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.